Yahoo
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that company management will participate in a DR3/TL1A focused panel discussion and participate in one-on-one meetings at the Leerink Partners Therapeutics Forum: II
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Yahoo
Shattuck Labs ( NASDAQ:STTK ) First Quarter 2025 Results Key Financial Results Net loss: US$13.7m (loss narrowed by 26...
Yahoo
– Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-
Yahoo
Amid ongoing market volatility and tariff uncertainties, the S&P 500 and Dow Jones Industrial Average have experienced significant declines, while the Nasdaq Composite showed a slight increase. For investors willing to explore beyond well-known companies, penny stocks—often associated with smaller or newer enterprises—can present unexpected opportunities. Despite their somewhat outdated label, these stocks remain relevant for those seeking potential growth driven by solid financial health.
Yahoo
AUSTIN, TX and DURHAM, NC, April 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that company management will present at and participate in one-on-one meetings at the 24th Annual Needham Virtual Healthcare Conference, taking place April 7–10, 202
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILS | -0.02% | $3.81B | 0.1356% |
DFAE | 0.03% | $6.08B | 0.35% |
DWX | 0.09% | $478.17M | 0.45% |
SEIX | 0.10% | $308.66M | 0.57% |
USFR | -0.10% | $18.56B | 0.15% |
DFEV | 0.11% | $1.04B | 0.43% |
PREF | -0.12% | $1.23B | 0.55% |
URNJ | -0.17% | $307.35M | 0.8% |
HYLS | 0.17% | $1.69B | 1.02% |
FALN | 0.17% | $1.82B | 0.25% |
VRP | 0.18% | $2.11B | 0.5% |
IEMG | 0.20% | $95.71B | 0.09% |
UPAR | -0.21% | $57.92M | 0.65% |
BYLD | 0.26% | $248.85M | 0.17% |
GSY | 0.28% | $2.74B | 0.22% |
XSOE | 0.29% | $1.87B | 0.32% |
URNM | 0.34% | $1.75B | 0.75% |
GLTR | 0.41% | $1.44B | 0.6% |
VNLA | 0.44% | $2.62B | 0.23% |
FICS | -0.47% | $223.48M | 0.7% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ICLO | 36.32% | $316.83M | 0.19% |
CLOI | 32.64% | $1.05B | 0.4% |
IBB | 27.67% | $5.26B | 0.45% |
XBI | 27.59% | $4.82B | 0.35% |
FLRN | 27.30% | $2.76B | 0.15% |
HEQT | 27.09% | $331.62M | 0.44% |
PBE | 26.75% | $223.19M | 0.58% |
THTA | 25.41% | $35.69M | 0.61% |
ARKG | 25.37% | $1.02B | 0.75% |
FTSL | 25.26% | $2.40B | 0.87% |
MOAT | 25.24% | $12.66B | 0.47% |
GNOM | 25.10% | $44.57M | 0.5% |
PSFF | 24.86% | $481.54M | 0.75% |
XHE | 24.82% | $166.72M | 0.35% |
XPH | 24.75% | $147.96M | 0.35% |
FBT | 24.71% | $1.01B | 0.54% |
XRT | 24.54% | $158.06M | 0.35% |
KJUL | 24.42% | $119.50M | 0.79% |
IWC | 24.42% | $818.14M | 0.6% |
BBH | 24.38% | $330.62M | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SITC | -22.16% | $612.56M | +16.76% | 0.00% |
VSTA | -21.30% | $344.07M | +39.29% | 0.00% |
CBOE | -18.30% | $24.23B | +35.36% | 1.09% |
API | -17.88% | $275.52M | +57.45% | 0.00% |
YRD | -16.74% | $531.40M | +27.86% | 6.80% |
TIGR | -16.51% | $1.63B | +115.54% | 0.00% |
BEKE | -15.85% | $20.23B | +11.64% | 2.03% |
DAO | -14.49% | $262.76M | +119.32% | 0.00% |
TRIN | -14.40% | $918.04M | -0.84% | 14.33% |
IMAB | -14.12% | $180.77M | +52.67% | 0.00% |
LX | -13.59% | $925.49M | +320.48% | 2.62% |
K | -12.69% | $27.76B | +41.17% | 2.85% |
PRPO | -12.42% | $17.08M | +125.94% | 0.00% |
FINV | -12.10% | $1.33B | +95.68% | 2.92% |
GLAD | -11.40% | - | - | 7.25% |
BABA | -11.25% | $247.59B | +47.67% | 0.97% |
ABEV | -11.24% | $38.96B | +19.71% | 5.28% |
FMX | -11.16% | $21.86B | +1.89% | 4.23% |
WDI | -10.99% | - | - | 11.98% |
PHYS.U | -10.92% | - | - | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VRIG | -35.04% | $1.21B | 0.3% |
SMB | -34.42% | $274.97M | 0.07% |
SUB | -34.06% | $9.91B | 0.07% |
SHYM | -33.42% | $357.13M | 0.35% |
SHYD | -32.01% | $332.63M | 0.35% |
MMIT | -31.91% | $1.03B | 0.3% |
DFNM | -31.28% | $1.57B | 0.17% |
HYD | -30.76% | $3.32B | 0.32% |
MLN | -29.50% | $541.74M | 0.24% |
JMST | -28.21% | $4.06B | 0.18% |
HYMB | -28.01% | $2.63B | 0.35% |
PZA | -27.20% | $2.84B | 0.28% |
ITM | -26.63% | $1.87B | 0.18% |
CMF | -26.48% | $3.59B | 0.08% |
MEAR | -26.29% | $1.13B | 0.25% |
FMB | -25.34% | $1.90B | 0.65% |
FMHI | -25.00% | $754.85M | 0.7% |
ASHR | -24.46% | $1.91B | 0.65% |
CNYA | -24.06% | $195.82M | 0.6% |
LMBS | -23.97% | $5.11B | 0.64% |
Current Value
$0.871 Year Return
Current Value
$0.871 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DFDV | 55.24% | $300.56M | +2,130.16% | 0.00% |
LFUS | 32.98% | $5.87B | -6.00% | 1.17% |
QGEN | 32.91% | $10.53B | +16.53% | 0.51% |
ROG | 31.53% | $1.36B | -39.03% | 0.00% |
IMKTA | 30.15% | $1.24B | -1.85% | 1.00% |
FATE | 30.13% | $128.39M | -64.56% | 0.00% |
SPWH | 28.92% | $126.83M | +56.87% | 0.00% |
RCUS | 28.79% | $909.55M | -40.18% | 0.00% |
VRCA | 28.70% | $59.96M | -91.36% | 0.00% |
W | 28.21% | $7.24B | +9.65% | 0.00% |
APGE | 27.85% | $2.64B | +18.19% | 0.00% |
INNV | 27.66% | $560.30M | -17.98% | 0.00% |
CLDX | 27.09% | $1.47B | -38.43% | 0.00% |
IONS | 27.08% | $6.94B | -4.41% | 0.00% |
RH | 26.91% | $3.86B | -14.51% | 0.00% |
IDYA | 26.88% | $1.92B | -34.15% | 0.00% |
BRDG | 26.78% | $450.36M | +32.07% | 3.35% |
BRKR | 26.44% | $6.43B | -31.33% | 0.47% |
STNG | 26.34% | $2.14B | -48.70% | 3.80% |
RYTM | 25.97% | $4.26B | +63.98% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | <0.01% | $6.79B | +102.19% | 0.00% |
CSWC | 0.01% | $1.24B | -14.66% | 10.25% |
CLX | 0.01% | $15.36B | -5.89% | 3.90% |
UUU | -0.02% | $7.17M | +101.30% | 0.00% |
FRHC | 0.02% | $8.54B | +85.42% | 0.00% |
LDOS | 0.03% | $20.93B | +10.90% | 0.96% |
DSP | -0.03% | $832.76M | +28.66% | 0.00% |
PSEC | -0.03% | - | - | 18.24% |
CWEN.A | -0.06% | $3.56B | +34.52% | 5.66% |
ERJ | 0.06% | $10.89B | +120.54% | 0.00% |
FSP | 0.06% | $183.31M | +14.19% | 2.26% |
WRAP | 0.07% | $78.39M | -14.84% | 0.00% |
PCRX | 0.07% | $1.07B | +7.16% | 0.00% |
IMO | -0.07% | $41.22B | +16.30% | 2.36% |
WDS | 0.07% | $30.01B | -19.19% | 7.72% |
COKE | -0.08% | $9.06B | +6.17% | 6.89% |
LFWD | 0.09% | $10.50M | -81.82% | 0.00% |
APEI | 0.09% | $528.02M | +67.83% | 0.00% |
BXSL | -0.09% | - | - | 9.96% |
QD | 0.09% | $305.92M | +60.96% | 0.00% |